Friess Associates’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-82,498
Closed -$3.03M 88
2021
Q1
$3.03M Sell
82,498
-2,896
-3% -$102K 1.18% 33
2020
Q4
$3.21M Sell
85,394
-72,929
-46% -$2.26M 0.24% 73
2020
Q3
$3.45M Sell
158,323
-4,291
-3% -$90.1K 0.3% 61
2020
Q2
$2.62M Sell
162,614
-74,083
-31% -$1.24M 0.24% 70
2020
Q1
$3.79M Buy
+236,697
New +$3.34M 0.38% 71

Other funds holding AHCO

Friess Associates's AHCO Position: Q2 2021 in Review

Friess Associates sold out of AdaptHealth (AHCO) in Q2 2021, closing a stake of 82,498 shares — an estimated $3.03M sold.

Friess Associates first reported a position in AHCO in Q1 2020 and held it in 5 quarters. The position peaked at $3.79M in Q1 2020. 137 funds tracked by Wall St. Rank hold AHCO as of Q2 2021.

  • Friess Associates reported no remaining AdaptHealth position as of Q2 2021 after selling out during the quarter.
  • Friess Associates sold 82,498 AdaptHealth shares in Q2 2021, an estimated $3.03M.
  • Friess Associates first reported a position in AdaptHealth in Q1 2020 and held it in 5 quarters.
  • Friess Associates's AdaptHealth position peaked at $3.79M in Q1 2020.
  • 137 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2021.

Based on Friess Associates's 13F filing for Q2 2021, filed 11 Aug 2021.